Australians living with generalised myasthenia gravis (gMG) may be eligible to participate in the MyClad Study, a clinical research study that is currently enrolling participants.
The MyClad Study is researching an investigational medication taken by mouth for people living with gMG. The study aims to learn more about the safety of the investigational medication and its ability to improve gMG symptoms.
Who may be eligible?
You may be eligible to participate in the MyClad Study if you:
- are aged 18 years or older
- have a confirmed diagnosis of myasthenia gravis with generalised muscle weakness.
Your doctor or the study team will review the full study requirements and discuss your eligibility with you.
All study-related procedures and the investigational medication are provided at no cost to participants. Participation in the study is expected to last approximately three years.
Find your nearest MyClad Study Centre
The MyClad Study is open to eligible participants in Australia, with study centres located across the country.
To find the study centre nearest to you, visit the MyClad Study website and enter your postcode using the Find Your Nearest Study Centre search.
Find out more
If you are interested in participating in the MyClad Study, speak with your treating doctor about whether the study may be suitable for you.
You can also find further information in the MyClad participant resources below, including more information about the study, eligibility and what participation may involve.
Download the MyClad Patient Flyer
Clinical trials play an important role in advancing our understanding of myasthenia gravis and exploring potential future treatment options. Myasthenia Alliance Australia is pleased to help make the Australian MG community aware of opportunities to participate in research.
Participation in any clinical trial is voluntary. This information is provided for general awareness and does not constitute medical advice or an endorsement of the investigational treatment. Please discuss your individual circumstances with your healthcare professional and the relevant study team.